台股 » 個股 » 台康生技 » 籌碼相關 » 融資融券與借券

台康生技

(6589)
可現股當沖
  • 股價
    51.2
  • 漲跌
    ▼0.4
  • 漲幅
    -0.78%
  • 成交量
    724
  • 產業
    上市 生技醫療類股
  • 520人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
台康生技 (6589) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

台康生技 (6589) 融資融券與借券

台康生技 (6589) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
08/21-182,7274.334110.02000.451.2-0.78%728
08/20-682,7454.36070.01000.2651.63.51%1,138
08/19212,8134.46070.0110.140.2549.852.36%719
08/18-102,7924.43270.01000.2548.70.00%324
08/17562,8024.45150.0110.110.1848.7-5.44%942
08/14-12,7464.36-740.01000.1551.51.38%655
08/13-592,7474.360110.02000.450.8-0.59%648
08/12532,8064.457110.0230.350.3951.1-2.85%864
08/11-1212,7534.37240.0110.070.1552.63.75%1,432
08/10-382,8744.56020000.0750.75.19%1,553
08/07-272,9124.62020000.0748.20.42%466
08/0602,9394.66020000.0748-1.34%550
08/05-362,9394.6602060.620.0748.652.64%968
08/04-32,9754.72020000.0747.42.82%680
08/03-192,9784.73220000.0746.12.79%573
07/31132,9974.7600000044.85-0.44%648
07/30-342,9844.7400000045.05-1.74%495
07/29153,0184.7900000045.85-0.22%895
07/28-233,0034.7700000045.95-2.34%450
07/27-383,0264.800000047.053.18%625
07/24-183,0644.8600000045.60.00%277
07/23-83,0824.8900000045.6-2.15%448
07/22-263,0904.9-370000046.62.42%478
07/21-133,1164.940370.06001.1945.51.34%356
07/20-143,1294.97-2370.06001.1844.90.11%468
07/17-403,1434.990390.06001.2444.85-3.03%832
07/16183,1835.05-2390.06001.2346.25-2.22%772
07/15-263,1655.02-1410.07001.347.31.50%559
07/14713,1915.07-33420.07001.3246.6-7.91%1,866
07/13-423,1204.9538750.12002.450.64.87%1,495
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
08/21040411@Limit20.02112610-2506,23451.2-0.78%728
08/2000007@Limit20.01171430-1266,48451.63.51%1,138
08/1900007@Limit20.014000406,61049.852.36%719
08/1802027@Limit20.01125220-5106,57048.70.00%324
08/1712015@Limit20.01671780-1117,08048.7-5.44%942
08/14700-74@Limit20.010800-807,19151.51.38%655
08/13000011@Limit20.0230037,27150.8-0.59%648
08/12070711@Limit20.0238640-267,26851.1-2.85%864
08/1102024@Limit20.012950-937,29452.63.75%1,432
08/1000002@Limit2060067,38750.75.19%1,553
08/0700002@Limit2082950-2877,38148.20.42%466
08/0600002@Limit2050530-37,66848-1.34%550
08/0500002@Limit20401000-607,67148.652.64%968
08/0400002@Limit20602540-1947,73147.42.82%680
08/0302022@Limit202618087,92546.12.79%573
07/3100000@Limit20541360-827,91744.85-0.44%648
07/3000000@Limit2054340207,99945.05-1.74%495
07/2900000@Limit2044310137,97945.85-0.22%895
07/2800000@Limit208210-137,96645.95-2.34%450
07/2700000@Limit202500257,97947.053.18%625
07/2400000@Limit2018640-467,95445.60.00%277
07/2300000@Limit2069300398,00045.6-2.15%448
07/223700-370@Limit2027850-587,96146.62.42%478
07/21000037@Limit20.068500858,01945.51.34%356
07/20200-237@Limit20.068000807,93444.90.11%468
07/17000039@Limit20.06116180987,85444.85-3.03%832
07/16200-239@Limit20.063028802147,75646.25-2.22%772
07/15100-141@Limit20.07741140-407,54247.31.50%559
07/143630-3342@Limit20.074332004137,58246.6-7.91%1,866
07/1303803875@Limit20.123358402517,16950.64.87%1,495
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
08/211879,633,0009,632,20025.68-4.28
08/2042622,012,00022,022,30037.4324.18
08/191929,464,4009,468,45026.721.09
08/181105,353,4505,360,0003459.55
08/171567,716,7007,762,50016.56293.59
08/141377,032,7007,075,10020.91309.49
08/131447,305,0007,339,80022.24241.67
08/1228114,511,90014,525,40032.5348.04
08/1125513,160,70013,266,90017.81416.47
08/1036518,607,10018,756,90023.51410.41
08/07994,773,3004,775,90021.2626.26
08/061878,930,2508,935,7003429.14
08/0526912,834,80012,922,85027.79327.32
08/0428412,955,95013,077,05041.79426.41
08/031778,065,0008,070,90030.9133.33
07/3123210,609,75010,575,85035.81-146.12
07/301868,453,5508,462,85037.5950
07/2931014,238,35014,270,05034.63102.26
07/281587,319,1507,331,70035.179.43
07/271095,075,8505,100,50017.44226.15
07/24713,232,8503,236,65025.6553.52
07/231456,703,5006,703,25032.36-1.72
07/22924,243,3004,265,25019.25238.59
07/21632,869,5002,877,40017.68125.4
07/201346,015,3506,040,80028.61189.93
07/171788,075,9008,072,00021.41-21.91
07/161718,015,7508,030,75022.1687.72
07/151245,789,0505,823,90022.18281.05
07/1457927,305,25027,363,40031.02100.43
07/1334116,780,20016,857,70022.81227.27
台康生技乳癌生物相似藥與日藥廠簽署授權、受惠健保擴大給付雙喜臨門Anue鉅亨-2026/06/30
台康生技持續推進8個生物相似藥產品線 可望帶動授權金與分潤收入Anue鉅亨-2026/06/18
台康生技 相關文章
台康生技 相關影音